Products for Research Use Only

Anti-RELB Antibody

CAT: 0519-M00836-2-200ulSize: 200 µLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0519-M00836-2-200ulSize:200 µL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52.
Description
Boster Bio Anti-RELB Antibody (Catalog # M00836-2) . Tested in WB application (s) . This antibody reacts with Human, Mouse.
Synonyms
Transcription factor RelB, I-Rel, RELB
Gene Name
RELB
UniProt
Q01201
Host
Mouse
Reactivity
Human, Mouse
Immunogen
This RELB antibody is generated from a mouse immunized with a recombinant protein human RELB.
Clonality
Monoclonal
Clone
Clone: 1684CT450.20.25
Applications
WB
Field of Research
Cancer, Cell Biology, Signal Transduction, Immunology, Inflammation, Apoptosis
Purification
This antibody is purified through a protein G column, followed by dialysis against PBS.
Function
26385063
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long-term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
Observed Molecular Weight
62134 Da
Applications Notes
WB: 1:5000
Subcellular Location
Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Colocalizes with NEK6 in the centrosome
Isotype
IgG1, k
Contents
Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.

UniProtKB · Q01201

Transcription factor RelB

RELB_HUMAN · Homo sapiens

View on UniProt ↗
Primary accession
Q01201
Review status
UniProtKB reviewed (Swiss-Prot)
Gene
RELB
Protein existence
1: Evidence at protein level
Organism
Homo sapiens (Human)
Taxonomy ID
9606
Alternative names
—
EC number
—
Processing
—
Secondary accessions
Q6GTX7, Q9UEI7
Protein keywords

Technical term

3D-structureProteomics identificationReference proteome

Molecular function

ActivatorDNA-bindingRepressor

Biological process

Biological rhythmsTranscriptionTranscription regulation

Cellular component

CytoplasmCytoskeletonNucleus

Disease

Disease variant

PTM

MethylationPhosphoprotein